Impax Laboratories - M&A Summary and Business Overview

Life ScienceCompany

Impax Laboratories M&A Summary

Impax Laboratories has acquired 6 companies. A total of 2 acquisitions came from private equity firms. It has also divested 3 assets.

Impax Laboratories’ largest acquisition to date was in 2016, when it acquired Teva Pharmaceutical Industries - Generic Products for $586M. Impax Laboratories has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

Impax Laboratories Business Overview

Where is Impax Laboratories headquartered?

Impax Laboratories is headquartered in Hayward, California.

What is Impax Laboratories’ revenue?

Impax Laboratories disclosed revenue of 860M USD for 2015 and 596M USD for 2014.

How many employees does Impax Laboratories have?

Impax Laboratories has 1,290 employees.

What sector is Impax Laboratories in?

Impax Laboratories is a life science company.

When was Impax Laboratories founded?

Impax Laboratories was founded in 1993.

M&A Summary

  • M&A Total Activity9
    • M&A Buy Activity6
    • M&A Sell Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 7
  • M&A Advisors 4

Impax Laboratories, Inc.

30831 Huntwood Avenue,
Hayward, California 94544
United States,
(510) 476-2000
www.impaxlabs.com

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company that applies formulation and development techniques, as well as drug delivery technology, to the development, manufacture and marketing of bioequivalent pharmaceutical products. Impax operates in two segments. These include global pharmaceuticals and Impax pharmaceuticals. The global division develops, manufactures, and distributes generic products. The Impax division develops proprietary brand pharmaceutical products that the Company believes represent improvements to already-approved pharmaceutical products addressing the treatment of central nervous system disorders. Impax Laboratories, Inc. was formed in 1993 and is based in Hayward, California.


M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (0.8/yr) # 2 1 2 1 - - 6
vol $586M $586M
Sell (0.6/yr) # - - 1 - - 2 3
  9

Most Recent M&A

Company Date Value Type
Impax Laboratories, Inc. - Generic Products and Assets 2018-04-27 - Divestiture
Hayward, California
CorePharma LLC 2018-01-30 - Unknown
Middlesex, New Jersey · www.corepharma.com
Teva Pharmaceutical Industries Ltd. - Generic Products 2016-06-21 586M USD Divestiture
Petach Tikva, Israel
Impax Laboratories - Daraprim 2015-08-10 - Divestiture
Hayward, California
Lineage Therapeutics, Inc. 2015-03-10 - Add-on Acquisition
Horsham, Pennsylvania · www.lineagetherapeutics.com
Tower Holdings, Inc. 2015-03-10 - Add-on Acquisition
Horsham, Pennsylvania
Actavis - Two Generic Products 2014-07-02 - Divestiture
, United States
Watson Pharmaceuticals - Abbreviated New Drug Application 2009-12-02 - Divestiture
, United States
Cobalt Laboratories - Abbreviated New Drug Application 2009-12-02 - Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 6 (100%) 586M (100%) 2 (67%) -
Medical Products - - 1 (33%) -
Total 6 $586M 3 -

By Geo

State/Country Buy Value Sell Value
United States 5 - 3 -
  Pennsylvania 2 - - -
  California - - 2 -
  New Jersey - - 1 -
Israel 1 586M - -
Domestic 5 (83%) - 3 (100%) -
Cross-border 1 (17%) 586M (100%) - -
Total 6 $586M 3 -

Top M&A Advisors

Financial Deals
Barclays Investment Bank
2
Legal Deals
Sullivan & Cromwell
3
McDermott Will & Emery
3
Latham & Watkins
2

Deal Values

buy # Total
$100M to $1B 1 $586M
TOTAL $586M
Largest Teva Pharmaceutical Industries Ltd. - Generic Products
$586M (2016-06-21)

M&A Connections

Deals
Acquired from
Investor(s)
33%
2 (33%)
Strategic(s)
67%
4 (67%)
Divested to
Strategic(s)
67%
2 (67%)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.